August 2, 2024
Docket Number: FDA-2022-D-1527 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research, Office of Regulatory Policy Center for Biologics Evaluation and Research The Food […]
August 2, 2024
The US Food and Drug Administration (FDA) has expanded the approval of dostarlimab-gxly (Jemperli, GSK) in conjunction with carboplatin and paclitaxel, followed by single-agent dostarlimab-gxly, for […]
August 2, 2024
CHICAGO — Being hormone receptor positive is generally a favorable prognostic factor in breast cancer, but that doesn’t seem to be the case in women with […]
August 2, 2024
TOPLINE: Since 2014, opioid use for autoimmune rheumatic decreased by 15% annually while other management modalities increased or stabilized. METHODOLOGY: Researchers analyzed de-identified US claims data […]
August 2, 2024
As a young musical comic playing the New York club scene in the 1980s, Stuart Bloom had big dreams. “I was going to be rich and […]
August 2, 2024
TOPLINE: Black and Native American people had the highest rate of firearm injuries, according to a study published in Annals of Internal Medicine. METHODOLOGY: The study […]
August 2, 2024
The European Alliance of Associations for Rheumatology (EULAR) has updated its recommendations regarding the involvement of so-called Patient Research Partners (PRPs) in scientific projects in rheumatology. […]
August 2, 2024
TOPLINE: In a retrospective cohort study, treatment with an IL-23 inhibitor was associated with a similar incidence of psoriatic arthritis (PsA) as treatment with IL-2/23 inhibitors […]
August 2, 2024
In the last 10 years, clinical outcomes have improved for patients with unresectable hepatocellular carcinoma (uHCC). The cancer generally comes with chronic liver inflammation, and liver […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623
Next page